These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15642152)

  • 1. Interleukin-18: a therapeutic target in rheumatoid arthritis?
    McInnes IB; Liew FY; Gracie JA
    Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
    Lubberts E; Koenders MI; van den Berg WB
    Arthritis Res Ther; 2005; 7(1):29-37. PubMed ID: 15642151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological roles for IL-18 in inflammatory arthritis.
    Matsui K; Tsutsui H; Nakanishi K
    Expert Opin Ther Targets; 2003 Dec; 7(6):701-24. PubMed ID: 14640907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
    Sánchez-Ramón S; López-Longo FJ; Carreño L
    Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 and the treatment of rheumatoid arthritis.
    Dinarello CA
    Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
    Abramson SB; Amin A
    Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that cytokines play a role in rheumatoid arthritis.
    Brennan FM; McInnes IB
    J Clin Invest; 2008 Nov; 118(11):3537-45. PubMed ID: 18982160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic opportunities in fibroblasts in inflammatory arthritis.
    Niedermeier M; Pap T; Korb A
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):527-40. PubMed ID: 20732650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.
    Li X; Yuan FL; Lu WG; Zhao YQ; Li CW; Li JP; Xu RS
    Biochem Biophys Res Commun; 2010 Jun; 397(2):131-5. PubMed ID: 20513356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embracing novel cytokines in RA - complexity grows as does opportunity!
    Hueber AJ; Asquith DL; McInnes IB; Miller AM
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors.
    Ballanti E; Perricone C; di Muzio G; Kroegler B; Chimenti MS; Graceffa D; Perricone R
    Autoimmun Rev; 2011 Aug; 10(10):617-23. PubMed ID: 21549221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.